New Hampshire Advances Proposal to Dispense Ivermectin TrialSite Staff

In the ongoing drive to allow access to ivermectin in states, legislators in New Hampshire have introduced, and taken the first step, on a bill allowing pharmacists to dispense the “controversial” COVID-19 treatment without a physicians prescription.

The State House Health, Human Services and Elderly Affairs Committee narrowly passed bill HB 1022 by a vote of 11-9. If the bill is passed by the New Hampshire legislature it will become law. According to the legislation a pharmacist may fill a request for the drug under a “standing order”. Supporters of the bill claimed the legislation will allow the medication to be dispensed by health care providers rather than patients buying, and using, the drug in its veterinary formula. “The committee’s endorsement of boosting access to ivermectin came over the criticism of Democrats on the committee. ‘I don’t think the legislature should be practicing medicine, which is basically what this is,’ said Rep. Gary Woods of Bow, a retired doctor and former president of the New Hampshire Medical Society.”

The Food and Drug Administration (FDA) has consistently referred to ivermectin as a “horse de wormer” and has recommended the medication not be used as a treatment for Covid-19.

Ivermectin Without a Prescription

Under the proposed New Hampshire law, COVID-19 sufferers who aren’t being treated by a doctor will be able to acquire what has in the past been termed a “wonder drug” due to the success in programs such as Mectizan.

Subscribe to the Trialsitenews "Ivermectin" Channel

No spam - we promise

“We still have patients who don’t know how to find the doctors who will write prescriptions for ivermectin,” said Rep. Leah Cushman, a nurse who represents Weare. “It’s safer than having to go to the farm store.”

In some ways the United States starts to resemble a developing nation when it comes to drug access. It’s one of the few rich nations that has large demand for ivermectin. Drug prescriptions raised from about 3,000 per week before the pandemic to nearly 90,000 during the pandemic. 

Ivermectin has been approved or authorized on an emergency and temporary basis in over 20 countries during the pandemic. In the U.S. because the FDA and various medical and pharmacy societies have decided to campaign against the drug’s use for COVID-19 few physicians nor pharmacies will write or fill a prescription. Consequently, accessing the drug for COVID-19 becomes ever more difficult.

Protection Against Mandates

The Health, Human Services and Elderly Affairs committee also moved forward a proposal which would bar the state from enforcing any federal vaccine mandates. This could complicate services for the elderly. Nursing homes rely on millions of dollars in federal funding for Medicare. The committee also rejected a bill requiring children get a COVID-19 vaccine to attend public school.

The growing trend of states supporting use of ivermectin has national implications and is supported by several Republican state’s Attorneys General who’ve written legal opinion letters on the subject. But as one of the New Hampshire Republican state legislators said, “these were not just brought out of thin air. They are a response to what we feel is the overplaying of a hand by the medical system.”

A major change in the Congress during midterm elections could complicate matters even more.